During this virtual tumor board, the participants will be able: 

• Review the role of resection as well as non-surgical therapies for patients with metastatic pheochromocytoma/paraganglioma
• Understand the importance of genetic testing in patients with pheochromocytoma/paraganglioma and its impact on potential malignant disease.
• Describe the predictors of durable survival following resection of localized and metastatic adrenocortical carcinoma.
• Discuss systemic therapy considerations (utility, type, sequencing) in patients being considered for resection of metastatic adrenocortical carcinoma

Moderating this session will Carmen Solorzano, MD, FACS, Vanderbilt University Medical Center

Panelists:

Heather Wachtel, MD, FACS, University of Pennsylvania

Colleen Marie Kiernan, MD, MPH, FACS, Vanderbilt University Medical Center

Paxton V. Dickson, MD, University of Tennessee Health Science Center

Jill Gilbert, MD, Vanderbilt-Ingram Cancer Center